Research location
Pinellas Park
Florida, United States
Advertisement
Research activity in Pinellas Park
Florida, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 70 trials and 71 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Pinellas Park
70 linked trials · page 1 of 2A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive DisorderNCT06254612 · 2024-03-25 · 1 site observation
COMPLETED
SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)NCT06140303 · 2024-02-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNCT06058013 · 2023-12-20 · 1 site observation
COMPLETED
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)NCT06077864 · 2023-11-20 · 1 site observation
COMPLETED
Extension for Community Health Outcomes (ECHO) Diabetes ProgramNCT06552923 · 2021-06-01 · 1 site observation
COMPLETED
Non-proliferative Diabetic Retinopathy Treated With RuncaciguatNCT04722991 · 2021-03-17 · 1 site observation
COMPLETED
Fenofibrate for Prevention of DR WorseningNCT04661358 · 2021-03-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 DiabetesNCT04560998 · 2020-10-01 · 1 site observation
COMPLETED
Study of a High-Dose Aflibercept in Participants With Diabetic Eye DiseaseNCT04429503 · 2020-06-29 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)NCT04442503 · 2020-06-08 · 1 site observation
COMPLETED
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil LevelNCT04133909 · 2019-10-30 · 1 site observation
COMPLETED
Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaNCT03917472 · 2019-07-17 · 1 site observation
COMPLETED
Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile InfectionNCT03497806 · 2018-05-01 · 1 site observation
COMPLETED
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02NCT03426345 · 2018-02-16 · 1 site observation
TERMINATED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04NCT03383146 · 2018-02-01 · 1 site observation
TERMINATED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03NCT03420781 · 2018-01-24 · 1 site observation
TERMINATED
PROMINENT-Eye Ancillary Study (Protocol AD)NCT03345901 · 2018-01-15 · 1 site observation
TERMINATED
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. DiffNCT03110133 · 2017-05-08 · 1 site observation
COMPLETED
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of ObesityNCT03013543 · 2017-02-10 · 1 site observation
COMPLETED
Evaluation of Glucose Control in Patients With DiabetesNCT04230889 · 2017-02-06 · 1 site observation
COMPLETED
A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)NCT02990806 · 2017-01-19 · 1 site observation
COMPLETED
A Study to Evaluate SAGE-217 in Participants With Severe Postpartum DepressionNCT02978326 · 2017-01-04 · 1 site observation
COMPLETED
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult VolunteersNCT02849977 · 2016-09-28 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)NCT02942004 · 2016-08-01 · 1 site observation
COMPLETED
A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)NCT02942017 · 2016-07-01 · 1 site observation
COMPLETED
Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid ArthritisNCT02799472 · 2016-06-15 · 1 site observation
COMPLETED
A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)NCT02706951 · 2016-03-23 · 1 site observation
COMPLETED
A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDsNCT02706847 · 2016-03-15 · 1 site observation
COMPLETED
Anti-VEGF Treatment for Prevention of PDR/DMENCT02634333 · 2016-01-01 · 1 site observation
COMPLETED
A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background MethotrexateNCT02147587 · 2014-06-01 · 1 site observation
COMPLETED
Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.NCT01966107 · 2013-10-16 · 1 site observation
COMPLETED
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863NCT01831804 · 2013-06-17 · 1 site observation
COMPLETED
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose AbnormalitiesNCT01715818 · 2012-12-01 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)NCT01601704 · 2012-06-01 · 1 site observation
TERMINATED
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's DiseaseNCT01561053 · 2012-04-19 · 1 site observation
COMPLETED
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 HypertensionNCT01508026 · 2012-01-01 · 1 site observation
COMPLETED
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.NCT01475721 · 2011-11-18 · 1 site observation
COMPLETED
Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes MellitusNCT01451398 · 2011-11-01 · 1 site observation
COMPLETED
A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) PatientsNCT01426789 · 2011-08-01 · 1 site observation
COMPLETED
12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes MellitusNCT01370005 · 2011-06-01 · 1 site observation
COMPLETED
An Open Label Study for Participants With Rheumatoid ArthritisNCT01215942 · 2011-06-01 · 1 site observation
TERMINATED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
A Study in Participants With Rheumatoid ArthritisNCT01202773 · 2011-01-01 · 1 site observation
TERMINATED
A Rheumatoid Arthritis Study in ParticipantsNCT01202760 · 2011-01-01 · 1 site observation
COMPLETED
Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)NCT01264770 · 2011-01-01 · 1 site observation
TERMINATED
Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)NCT01242514 · 2011-01-01 · 1 site observation
TERMINATED
A Rheumatoid Arthritis Study in Participants on a Background Treatment of MethotrexateNCT01198002 · 2010-12-01 · 1 site observation
TERMINATED
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) TherapyNCT01242488 · 2010-11-01 · 1 site observation
COMPLETED
Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)NCT01164579 · 2010-10-01 · 1 site observation
COMPLETED
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-studyNCT01194830 · 2010-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.